MétaCan
Menu
Back to cohort
Record W2581333567 · doi:10.1016/j.jalz.2006.05.2111

P4–370: Long–term survival of human CNS stem cells and their progeny in immunodeficient, plaque–producing APP transgenic mice

2006· article· en· W2581333567 on OpenAlexaff
George A. Carlson, Calanthe Wilson, Rebecca Young, Sherry Turner, David Westaway, Karen H. Ashe, Ann Tsukamoto, Karl Eckert, Monika Dohse, Priyanka Patel, Robert Tushinski, Stan Tamaki, Nobuko Uchida

Bibliographic record

VenueAlzheimer s & Dementia · 2006
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicPluripotent Stem Cells Research
Canadian institutionsUniversity of Toronto
Fundersnot available
KeywordsTransgeneGenetically modified mouseSevere combined immunodeficiencyStem cellBiologyTransplantationGenetic enhancementCell cultureCancer researchMolecular biologyPathologyImmunologyCell biologyMedicineInternal medicineGeneBiochemistryGenetics

Abstract

fetched live from OpenAlex

To be an effective therapy for Alzheimer's disease (AD), human central nervous system stem cells (hCNS–SC) must be able to engraft, proliferate and differentiate in an environment with high levels of Aβ peptide and amyloid plaques. Three transgenic mouse lines, Tg(APPNL)2576, Tg(APPNLI)19959 and Tg(APPNLI)CRND8, that differ in the levels of Aβ peptides and age at onset of amyloid plaque deposition were used to model this condition. The goal of this study was to evaluate the effects of Aβ and plaques on survival of hCNS–SC and their progeny. Plaques appear in Tg2576 mice by 10 months and in Tg19959 or TgCRND8 by 3 months. Immunodeficient transgenic lines incapable of rejecting transplanted human cells were produced by backcrossing to mice homozygous for the severe combined immunodeficiency (scid) allele of the Prkdc gene. Highly purified and well–characterized banked hCNS–SC lines were used for transplantation by stereotaxic injection into the lateral ventricles of neonatal or 1 day–old litters of scid/scid transgene–positive and transgene–negative mice. Engraftment was assessed 6 weeks after injection using monoclonal antibodies specific for human cytoplasmic antigens or nuclei; no effect of high level Aβ expression on human cell survival was seen in any of the Tg lines. Mice were aged and sampled periodically for engraftment. Human cells were easily identified in Tg(APP) and non–transgenic mice months after injection. To assess the feasibility of hCNS–SC therapy for AD patients, cells were injected stereotaxically into the hippocampi of adult scid/scid Tg(APP)19959 mice with established plaques. No effect on survival of the human cells was noted and many cells were found in close proximity to plaques. The finding that high Aβ levels or amyloid plaques did not compromise survival of the transplanted cells suggests the hCNS–SC transplantation in AD may be a viable neuronal replacement therapy. Prolonged survival of hCNS–SC in an AD–like environment suggests that transplanted stem cells might provide a new source of neuronal cells and also offers the option to use genetically modified cells as a vehicle for delivery of therapeutic proteins.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.004
Threshold uncertainty score0.015

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0000.001
Bibliometrics0.0010.000
Science and technology studies0.0000.001
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0040.003

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.021
GPT teacher head0.259
Teacher spread0.238 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2006
Admission routes1
Has abstractyes

Explore more

Same venueAlzheimer s & DementiaSame topicPluripotent Stem Cells ResearchFrench-language works237,207